NASDAQ · Analyst Forecast

Neurocrine Biosciences, Inc. (NBIX) Stock Forecast & Price Target

$162.86 NASDAQ: NBIX Market Cap $16.48B

Price as of Nov 18, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Neurocrine Biosciences, Inc. (NBIX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Neurocrine Biosciences, Inc., analysts forecast revenue rising from $2.84B in 2025 to $5.52B in 2030; the average estimate for 2030 earnings per share is $13.75; with published estimates ranging from $12.97 to $15.29; 21 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$162.86
Consensus targetThe average of the price targets analysts have published.$203.41
Median targetThe middle target, less affected by a single outlier.$210.00
Highest targetThe most optimistic published target.$225.00
Lowest targetThe most pessimistic published target.$165.00
Difference from priceHow far the consensus target sits from today’s price.+24.9%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$2.82B$2.84B$2.87B18
2026$3.93B$3.99B$4.05B18
2027$4.11B$4.57B$5.11B19
2028$4.73B$5.04B$5.74B21
2029$4.93B$5.16B$5.60B10
2030$5.28B$5.52B$6.00B14

Earnings per share forecast

YearLowAverageHighAnalysts
2025$4.90$5.04$5.4118
2026$6.68$7.33$7.9418
2027$6.63$9.70$12.8519
2028$8.58$11.99$17.9221
2029$11.87$12.59$14.0010
2030$12.97$13.75$15.2914

Neurocrine Biosciences, Inc. (NBIX) forecast — frequently asked questions

What is the analyst price target for Neurocrine Biosciences, Inc.?

Analysts covering Neurocrine Biosciences, Inc. (NBIX) have a consensus price target of $203.41, 24.9% above the current price of $162.86. Published targets range from $165.00 to $225.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Neurocrine Biosciences, Inc.'s earnings?

The average analyst estimate for Neurocrine Biosciences, Inc. (NBIX) earnings per share in 2030 is 13.75, with individual estimates between 12.97 and 15.29.

How much revenue is Neurocrine Biosciences, Inc. expected to make?

Analysts forecast Neurocrine Biosciences, Inc. (NBIX) revenue of $5.52B in 2030, based on 14 published estimates.

How many analysts cover NBIX?

21 analysts contribute estimates for Neurocrine Biosciences, Inc. (NBIX). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.